RYTM – rhythm pharmaceuticals, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

RYTM

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

3/17

11:33 am

rytm

Rating for RYTM

Low Report

Rating for RYTM

Report

3/17

11:33 am

rytm

Rating for RYTM

Low Report

Rating for RYTM

Report

3/17

10:36 am

rytm

Rating for RYTM

Low Report

Rating for RYTM

Report

3/17

10:36 am

rytm

Rating for RYTM

Low Report

Rating for RYTM

Report

3/17

07:47 am

rytm

Rating for RYTM

Low Report

Rating for RYTM

Report

3/17

07:47 am

rytm

Rating for RYTM

Low Report

Rating for RYTM

Report

3/17

07:09 am

rytm

Rating for RYTM

Low Report

Rating for RYTM

Report

3/17

07:09 am

rytm

Rating for RYTM

Low Report

Rating for RYTM

Report

3/12

09:02 am

rytm

Rating for RYTM

Low Report

Rating for RYTM

Report

3/12

09:02 am

rytm

Rating for RYTM

Low Report

Rating for RYTM

Report

3/12

08:07 am

rytm

Rhythm Pharmaceuticals (RYTM) had its "overweight" rating reaffirmed by Wells Fargo & Company.

Low Report

Rhythm Pharmaceuticals (RYTM) had its "overweight" rating reaffirmed by Wells Fargo & Company.

Report

3/2

02:24 pm

rytm

Rating for RYTM

Low Report

Rating for RYTM

Report

2/27

11:00 am

rytm

Rating for RYTM

Low Report

Rating for RYTM

Report

2/27

11:00 am

rytm

Rating for RYTM

Low Report

Rating for RYTM

Report

2/27

07:57 am

rytm

Rating for RYTM

Medium Report

Rating for RYTM

Report

2/27

07:57 am

rytm

Rating for RYTM

Medium Report

Rating for RYTM

Report

2/20

03:21 pm

rytm

Rhythm Pharmaceuticals (NASDAQ:RYTM) was upgraded by analysts at Royal Bank Of Canada to a "moderate buy" rating.

Low Report

Rhythm Pharmaceuticals (NASDAQ:RYTM) was upgraded by analysts at Royal Bank Of Canada to a "moderate buy" rating.

Report

2/20

03:21 pm

rytm

Rhythm Pharmaceuticals (NASDAQ:RYTM) was upgraded by analysts at Royal Bank Of Canada to a "moderate buy" rating.

Low Report

Rhythm Pharmaceuticals (NASDAQ:RYTM) was upgraded by analysts at Royal Bank Of Canada to a "moderate buy" rating.

Report

2/19

09:41 am

rytm

Rating for RYTM

Medium Report

Rating for RYTM

Report

2/19

09:41 am

rytm

Rating for RYTM

Medium Report

Rating for RYTM

Report

2/18

05:09 pm

rytm

Rhythm Pharmaceuticals (NASDAQ:RYTM) is now covered by analysts at Royal Bank Of Canada. They set an "outperform" rating on the stock.

Low Report

Rhythm Pharmaceuticals (NASDAQ:RYTM) is now covered by analysts at Royal Bank Of Canada. They set an "outperform" rating on the stock.

Report

2/18

05:09 pm

rytm

Rhythm Pharmaceuticals (NASDAQ:RYTM) is now covered by analysts at Royal Bank Of Canada. They set an "outperform" rating on the stock.

Low Report

Rhythm Pharmaceuticals (NASDAQ:RYTM) is now covered by analysts at Royal Bank Of Canada. They set an "outperform" rating on the stock.

Report

2/18

04:11 pm

rytm

Rhythm Pharmaceuticals initiated with an Outperform at RBC Capital

Low Report

Rhythm Pharmaceuticals initiated with an Outperform at RBC Capital

Report

2/18

04:11 pm

rytm

Rhythm Pharmaceuticals initiated with an Outperform at RBC Capital

Low Report

Rhythm Pharmaceuticals initiated with an Outperform at RBC Capital

Report

1/20

10:50 am

rytm

Rating for RYTM

Low Report

Rating for RYTM

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.